BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  BeyondSpring’s Lead Asset, Plinabulin, Recognized as 2017 National Science and Technology Major Project in China

  This recognition is in conjunction with China’s 13th “five-year plan” in which the country continues to cultivate major products, solve vital problems and implement projects that achieve qualitative change in the world.

  December 4, 2017

   · 

  4 min read
• 

  Deals

  The Cooper Companies Pays $80M for Paragon Vision Sciences

  Paragon had trailing twelve month revenues of approximately $15 million and is forecasted to grow low double digits over the coming years.

  December 4, 2017

   · 

  7 min read
• Business

  GW Pharmaceuticals Reports Fiscal Fourth Quarter 2017 and Year-End Financial Results and Operational Progress

  Cash and cash equivalents at 30 September 2017 of £241.2 million ($322.2 million) compared to £374.4 million as at 30 September 2016..

  December 4, 2017

   · 

  14 min read
• Drug Development

  Lakewood-Amedex Advances Bisphosphocin Nu-8 to IND-Enabling Studies to Treat Complicated Urinary Tract Infection

  Lakewood-Amedex today announced that it will be advancing a second Bisphosphocin drug candidate, Nu-8, into preclinical IND-enabling studies.

  December 4, 2017

   · 

  3 min read
• Valeant Pharma Announces Launch of Private Offering of Senior Notes

  The Company also announced today that it has provided notice to its lenders of its intent to repay $175M of amounts outstanding under its revolving credit facility this week, using cash on hand.

  December 4, 2017

   · 

  3 min read
• Novo Nordisk A/S: Share Repurchase Programme - Dec. 4, 2017

  This programme is part of the overall share repurchase programme of up to DKK 17 billion to be executed during a 12-month period beginning 2 February 2017.

  December 4, 2017

   · 

  1 min read
• Biotech Beach

  ReShape Lifesciences Announces Coverage of ReShape Dual Balloon by Major Telecom Company

  ReShape Lifesciences announced today that their ReShape Integrated Dual Balloon technology has been granted employee coverage.

  December 4, 2017

   · 

  4 min read
• Drug Development

  Sanofi’s Toujeo Met Main Objective in Head-to-Head Study Versus Insulin Degludec

  First head-to-head randomized clinical trial comparing the efficacy and safety of Toujeo (insulin glargine 300 Units/mL) versus insulin degludec.

  December 4, 2017

   · 

  4 min read
• FDA

  Lundbeck’s Brintellix Approved in China

  The expected launch of Brintellix in Q2 2018 will enable Lundbeck to make an even bigger difference for the many patients and caregivers affected by depression in China.

  December 4, 2017

   · 

  4 min read
• Business

  Medigus Announces Distribution Agreement With Micro-Tech Europe for the MUSE System in Germany

  Under the terms of the agreement, Micro-Tech Europe will be the exclusive distributor for the MUSE System in Germany.

  December 4, 2017

   · 

  4 min read